Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY

Mid Cap | Pharmaceuticals & Drugs

1234.60

-10.90 (-0.88%)

< Home < Back

Dr. Reddy's launches generic version of Sapropterin Dihydrochloride Tablets

Date: 05-10-2020

Dr. Reddy’s Laboratories has launched a generic version of Sapropterin Dihydrochloride Tablets, for Oral Use. The company’s Sapropterin Dihydrochloride Tablets, 100 mg are available in bottle count sizes of 120.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.